| abstract |
A combination therapy for treating androgen deficiency is provided. The present invention relates to a combination therapy for increasing testosterone levels in a male mammal, wherein the anti-estrogen agent or a pharmaceutically acceptable salt thereof is selected from an androgen and an aromatase inhibitor. It relates to combination therapies that are co-administered with a drug to a mammal. The present invention also includes hypogonadism, including decreased muscle mass, limited work capacity of the body, decreased bone density, decreased libido, decreased sexual performance, decreased benign prostatic hypertrophy and infertility, and Combination therapy to treat men with related disorders is also targeted. [Selection] Figure 1 |